SUBSCRIBE
SUBSCRIBE
News   Policy

Potential Roadblock For ImClone Systems Incorporated (JOBS) Deal

October 28, 2008 | 
1 min read
Although it spent weeks teasing investors about the identity of its suitor, ImClone failed to satisfy all of its shareholders that a $6.5 billion bid from Eli Lilly fairly values the biotech business.
Legal Mergers & acquisitions
Eli Lilly and Company
MORE ON THIS TOPIC
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul
July 7, 2025
 · 
3 min read
 · 
Tristan Manalac
Social media illustration, business concept, web design
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
 · 
3 min read
 · 
Annalee Armstrong
Close-Up Of Syringe With Bottles Against Blue Background
RSV
Kennedy Follows RSV Recommendations of ACIP Members He Fired
July 3, 2025
 · 
3 min read
 · 
Tristan Manalac
Megaphone with stethoscope isolated on orange background. 3d illustration
Women’s health
Biotech Leaders, Investors Ask FDA to Maintain Access to Mifepristone
July 3, 2025
 · 
2 min read
 · 
Tristan Manalac